Algo version: 0.98b
PT Sarana Meditama is listed at the JKT Exchange
PT Sarana Meditama [SAME.JK]
JKT Sector: Healthcare Industry:Medical Care Facilities

Is PT Sarana Meditama stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, PT Sarana Meditama pays dividends. Last time was Thursday 7th of June 2018 where the investors holding the stock on Friday 18th of May 2018 were paid IDR1.10638 per share. Over the last 4 times between 2015 and 2018, PT Sarana Meditama has paid IDR12.17018 with an average of IDR3.04 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for PT Sarana Meditama 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was IDR484.00, you would have made a loss of IDR-216.00 per share or -44.63%

Yes, the average daily trading liquidity for PT Sarana Meditama is IDR2.32 million. You should therefore be able to get in and out of your positions relatively fast.

PT Sarana Meditama has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.22, the company's ability to pay off the debt is normal. The company has a very low net profit margin of 0.74%, which is challenging.

We have calculated the inflation risk for PT Sarana Meditama to be low [0.5 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.